AGIOS PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, April 13, 2017, a trademark application was filed for AGIOS PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the AGIOS PHARMACEUTICALS trademark a serial number of 87410256. The federal status of this trademark filing is REGISTERED as of Tuesday, December 3, 2019. This trademark is owned by Agios Pharmaceuticals, Inc.. The AGIOS PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer
agios pharmaceuticals

General Information

Serial Number87410256
Word MarkAGIOS PHARMACEUTICALS
Filing DateThursday, April 13, 2017
Status700 - REGISTERED
Status DateTuesday, December 3, 2019
Registration Number5927013
Registration DateTuesday, December 3, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2018

Trademark Statements

Goods and ServicesAnti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer
Translation of Words in MarkThe English translation of "AGIOS" in the mark is "SAINT".
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 20, 2017
Primary Code005
First Use Anywhere DateFriday, July 20, 2018
First Use In Commerce DateFriday, July 20, 2018

Trademark Owner History

Party NameAgios Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 021394169
Party NameAgios Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 021394169
Party NameAgios Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 021394169

Trademark Events

Event DateEvent Description
Monday, April 17, 2017NEW APPLICATION ENTERED
Monday, April 17, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, April 17, 2017TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, April 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 8, 2017ASSIGNED TO EXAMINER
Saturday, July 8, 2017NON-FINAL ACTION WRITTEN
Saturday, July 8, 2017NON-FINAL ACTION E-MAILED
Saturday, July 8, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 29, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, January 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, January 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 31, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 3, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, October 3, 2018USE AMENDMENT FILED
Monday, October 29, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 31, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, November 30, 2018SU - NON-FINAL ACTION - WRITTEN
Friday, November 30, 2018NON-FINAL ACTION E-MAILED
Friday, November 30, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 28, 2019ASSIGNED TO LIE
Tuesday, May 28, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 28, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 4, 2019SU - FINAL REFUSAL - WRITTEN
Tuesday, June 4, 2019FINAL REFUSAL E-MAILED
Tuesday, June 4, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 24, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, October 24, 2019EXPARTE APPEAL RECEIVED AT TTAB
Thursday, October 24, 2019JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, October 24, 2019EX PARTE APPEAL-INSTITUTED
Thursday, October 31, 2019ASSIGNED TO LIE
Thursday, October 31, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 1, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 3, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, February 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 3, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 3, 2019EXPARTE APPEAL TERMINATED

Related Keywords

pharmaceuticals agios cancer treatment preparations prevention biological pharmaceutical anti products